Hormonal Treatment and Depression

Past research has demonstrated a link between traditional prostate cancer hormone therapy (HT) and the risk of depression among prostate cancer patients.

A retrospective clinical trial investigated whether second-generation antiandrogens (AAs) are also associated with increased risk of depression.

Three treatments were compared during the study: no HT, traditional HT, and second-generation AA.

Results indicate that patients receiving a second-generation AA had an increased risk of depression compared with traditional HT alone or no HT.

These findings emphasize the need for emotional distress monitoring and the implantation of focused interventions to alleviate symptoms among these patients.

For more info:

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2787430.

This content is provided for your general education and information only. It does not necessarily reflect Belong’s views and opinions. Belong does not endorse or support any specific product, service or treatment.

More Articles

Communicating with Your Oncologist

Effective communication with your oncologist can greatly alleviate stress and ensure you receive the best…

Reflexology for Cancer Patients

While medical treatments are essential in alleviating pain, complementary therapies like reflexology could provide additional…

The Role of Spinal Taps in MS

Spinal taps, also known as lumbar punctures or cerebrospinal fluid (CSF) analyses, play a crucial…

3 Things to Know About Hair Loss After Chemo

Dealing with hair loss can be one of the most challenging aspects of undergoing chemotherapy,…

How Does Cold Weather Affect MS?

For people with multiple sclerosis (MS), the arrival of cold weather may bring challenges. Here…

What is Chemo Brain

If you’re currently undergoing chemotherapy, you might have come across the term ”chemo brain”. Chemo…
Skip to content